Lyka Labs Limited (NSE:LYKALABS)
India · Delayed Price · Currency is INR 82.90
-1.30 (-1.54%)
Sep 11, 2026, 3:15 PM IST
Lyka Labs Market Cap
Lyka Labs has a market cap or net worth of 3 billion as of September 11, 2026. Its market cap has decreased by -15.82% in one year.
Market Cap
3.00B
Enterprise Value
3.45B
Revenue
1.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
82.90
ChartMarket Cap Chart
Since October 1, 2003, Lyka Labs's market cap has increased from 294.62M to 3.00B, an increase of 917.25%. That is a compound annual growth rate of 10.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 3.00B | 10.65% |
| Dec 31, 2025 | 2.71B | -51.91% |
| Dec 31, 2024 | 5.63B | 37.55% |
| Dec 29, 2023 | 4.09B | 10.05% |
| Dec 30, 2022 | 3.72B | -41.66% |
| Dec 31, 2021 | 6.38B | 617.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 632.66B |
| Anthem Biosciences | 529.91B |
| OneSource Specialty Pharma | 182.54B |
| Concord Biotech | 157.52B |
| Blue Jet Healthcare | 107.61B |
| Supriya Lifescience | 72.58B |
| Zota Health Care | 37.65B |
| Dishman Carbogen Amcis | 26.22B |